<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04921293</url>
  </required_header>
  <id_info>
    <org_study_id>UIE-3652-21-22-1</org_study_id>
    <nct_id>NCT04921293</nct_id>
  </id_info>
  <brief_title>Comparison Between Endogenous and Exogenous Ketosis in Patients With Non-ischemic Chronic Heart Failure With Reduced Ejection Fraction</brief_title>
  <official_title>Comparison Between Endogenous and Exogenous Ketosis in Patients With Non-ischemic Chronic Heart Failure With Reduced Ejection Fraction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Oxford</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized controlled trial will evaluate the effect of a ketogenic diet and/or&#xD;
      exogenous administration of ketone bodies vs conventional diet on the ejection fraction of&#xD;
      patients with non-ischemic chronic heart failure, measuring MRI biomarkers.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Evidence in both animals and humans suggests ketosis could be beneficial for people living&#xD;
      with chronic heart failure. To date, no study has compared endogenous vs exogenous ketosis in&#xD;
      patients with chronic heart failure. We will randomize (with a 1:1:1 ratio) patients with a&#xD;
      confirmed diagnosis of non-ischemic chronic heart failure to undergo one of the following:&#xD;
&#xD;
        1. - A ketogenic diet (&lt;50 gr of carbohydrates per day) incorporating current&#xD;
           recommendations for heart failure (low sodium and liquids) for 10 days.&#xD;
&#xD;
        2. - Standard diet incorporating current recommendations for heart failure (low sodium and&#xD;
           liquids) and supplementation with exogenous ketones (ketone monoester) for 10 days.&#xD;
&#xD;
        3. - Standard diet incorporating current recommendations for heart failure (low sodium and&#xD;
           liquids) and supplementation with bitter taste placebo.&#xD;
&#xD;
      The endpoints will be assessed using cardiac MRI and blood biomarkers.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2021</start_date>
  <completion_date type="Anticipated">December 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">October 20, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized controlled trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ejection fraction Improvement</measure>
    <time_frame>10 days</time_frame>
    <description>Estimated by cardiac MRI</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical severity</measure>
    <time_frame>10 days</time_frame>
    <description>Estimated with the NYHA classification</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Liquid retention</measure>
    <time_frame>10 days</time_frame>
    <description>Estimated by electric bioimpedance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood biomarker</measure>
    <time_frame>10 days</time_frame>
    <description>BNP</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">18</enrollment>
  <condition>Heart Failure With Reduced Ejection Fraction</condition>
  <condition>Ketosis</condition>
  <arm_group>
    <arm_group_label>Standard Diet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard diet incorporating current recommendations for heart failure (low sodium and liquids) and supplementation with bitter taste placebo.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Endogenous Ketosis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ketogenic diet incorporating current recommendations for heart failure (&lt;50gr of carbohydrates, low sodium, and liquids) for 10 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Exogenous ketosis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Standard incorporating current recommendations for heart failure (low sodium and liquids) and supplementation with exogenous ketones (ketone monoester) for 10 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Ketogenic diet</intervention_name>
    <description>A diet with &lt;50gr of carbohydrates per day. Monosaturated fats consumption will encourage over saturated fats</description>
    <arm_group_label>Endogenous Ketosis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Exogenous ketones</intervention_name>
    <description>Administration of ketone monoester 25 ml t.i.d</description>
    <arm_group_label>Exogenous ketosis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Standard diet + placebo</intervention_name>
    <description>A standard diet incorporating current recommendations (low in sodium and low in liquids) for heart failure patients.</description>
    <arm_group_label>Standard Diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Ejection fraction &lt;40% minimum 1 month.&#xD;
&#xD;
          -  No change in optimum treatment 1 month at least.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Ischemic cardiopathy (Angio-tomography corroborated cut-point &gt;50% obstruction,&#xD;
             coronary angiography, or cardiac scintigraphy 6 months at least) or angina pectoris&#xD;
             symptoms.&#xD;
&#xD;
          -  Reynaud syndrome&#xD;
&#xD;
          -  Metformin or SGLT-2 Inhibitors treatment, Low BMI, nutritional deficiencies.&#xD;
&#xD;
          -  Creatinin clearance &lt;30ml/min or renal replacement therapy&#xD;
&#xD;
          -  MRI contraindications (prothesis, Unsupported pacemakers, claustrophobia, etc)&#xD;
&#xD;
          -  Reynaud phenomenon history&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adrian Soto, Ph.D, MD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>INCMNSZ</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Adrian Soto, Ph.D, MD.</last_name>
    <phone>5572191248</phone>
    <email>adrian.sotom@incmnsz.mx</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jorge Oseguera, MD</last_name>
    <phone>54870900</phone>
    <phone_ext>8210</phone_ext>
    <email>jorge.osegueram@incmnsz.mx</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>INCMNSZ</name>
      <address>
        <city>Mexico City</city>
        <state>Cdmx</state>
        <zip>14080</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <contact>
      <last_name>Adrian Soto, Ph.D, MD.</last_name>
      <phone>5572191248</phone>
      <email>adrian.sotom@incmnsz.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <reference>
    <citation>Astrup A, Magkos F, Bier DM, Brenna JT, de Oliveira Otto MC, Hill JO, King JC, Mente A, Ordovas JM, Volek JS, Yusuf S, Krauss RM. Saturated Fats and Health: A Reassessment and Proposal for Food-Based Recommendations: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020 Aug 18;76(7):844-857. doi: 10.1016/j.jacc.2020.05.077. Epub 2020 Jun 17. Review.</citation>
    <PMID>32562735</PMID>
  </reference>
  <reference>
    <citation>Athinarayanan SJ, Adams RN, Hallberg SJ, McKenzie AL, Bhanpuri NH, Campbell WW, Volek JS, Phinney SD, McCarter JP. Long-Term Effects of a Novel Continuous Remote Care Intervention Including Nutritional Ketosis for the Management of Type 2 Diabetes: A 2-Year Non-randomized Clinical Trial. Front Endocrinol (Lausanne). 2019 Jun 5;10:348. doi: 10.3389/fendo.2019.00348. eCollection 2019.</citation>
    <PMID>31231311</PMID>
  </reference>
  <reference>
    <citation>Aubert G, Martin OJ, Horton JL, Lai L, Vega RB, Leone TC, Koves T, Gardell SJ, Kr√ºger M, Hoppel CL, Lewandowski ED, Crawford PA, Muoio DM, Kelly DP. The Failing Heart Relies on Ketone Bodies as a Fuel. Circulation. 2016 Feb 23;133(8):698-705. doi: 10.1161/CIRCULATIONAHA.115.017355. Epub 2016 Jan 27. Erratum in: Circulation. 2018 Oct 9;138(15):e422.</citation>
    <PMID>26819376</PMID>
  </reference>
  <reference>
    <citation>Bertero E, Maack C. Metabolic remodelling in heart failure. Nat Rev Cardiol. 2018 Aug;15(8):457-470. doi: 10.1038/s41569-018-0044-6. Review.</citation>
    <PMID>29915254</PMID>
  </reference>
  <reference>
    <citation>Nielsen R, M√∏ller N, Gormsen LC, Tolbod LP, Hansson NH, Sorensen J, Harms HJ, Fr√∏ki√¶r J, Eiskjaer H, Jespersen NR, Mellemkjaer S, Lassen TR, Pryds K, B√∏tker HE, Wiggers H. Cardiovascular Effects of Treatment With the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients. Circulation. 2019 Apr 30;139(18):2129-2141. doi: 10.1161/CIRCULATIONAHA.118.036459.</citation>
    <PMID>30884964</PMID>
  </reference>
  <reference>
    <citation>Norwitz NG, Loh V. A Standard Lipid Panel Is Insufficient for the Care of a Patient on a High-Fat, Low-Carbohydrate Ketogenic Diet. Front Med (Lausanne). 2020 Apr 15;7:97. doi: 10.3389/fmed.2020.00097. eCollection 2020.</citation>
    <PMID>32351962</PMID>
  </reference>
  <reference>
    <citation>Soto-Mota A, Vansant H, Evans RD, Clarke K. Safety and tolerability of sustained exogenous ketosis using ketone monoester drinks for 28 days in healthy adults. Regul Toxicol Pharmacol. 2019 Dec;109:104506. doi: 10.1016/j.yrtph.2019.104506. Epub 2019 Oct 23.</citation>
    <PMID>31655093</PMID>
  </reference>
  <reference>
    <citation>Soto-Mota A, Norwitz NG, Clarke K. Why a d-Œ≤-hydroxybutyrate monoester? Biochem Soc Trans. 2020 Feb 28;48(1):51-59. doi: 10.1042/BST20190240. Review.</citation>
    <PMID>32096539</PMID>
  </reference>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>June 2, 2021</study_first_submitted>
  <study_first_submitted_qc>June 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 10, 2021</study_first_posted>
  <last_update_submitted>June 2, 2021</last_update_submitted>
  <last_update_submitted_qc>June 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Endogenous ketosis</keyword>
  <keyword>Exogenous ketosis</keyword>
  <keyword>Heart failure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Ketosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Upon request to PI</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>One year after publication</ipd_time_frame>
    <ipd_access_criteria>Send email to adrian.sotom@incmnsz.mx</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

